You’ve probably heard about incubators and accelerators that help startups scale up before they could stand on their own. 

But what about a venture platform dubbed as a super incubator? 

That’s what we’re going to talk about today. Founded in 2022, VentureBlick is a Singapore headquartered Super Incubator with a presence in countries such as Australia, China, South Korea, India, Germany and the US.

It matches early-stage startups with medical investors such as clinicians and industry experts who can validate ideas, fund and support the firms without diluting startup control. 

The aim is to provide a fully customisable one-stop solution to build, test and market innovations with the ultimate goal of successful exits or commercialisation. 

But really how does this proposition differ from the ones provided by other venture platforms? 

Meanwhile, VentureBlick recently secured a total of US$2.6 million for two startups amid the current macroeconomic environment. But what is in VentureBlick’s pipeline for the rest of this year?

On Under the Radar, Drive Time’s finance presenter Chua Tian Tian sat down with Chris Lee, Founder and CEO, VentureBlick for more.